Obamacare Website Traffic Is Surprising Experts (and Frustrating Obama Opponents)

Source: Huffington Post/Pro Publica It turned out that more than 5 million people signed up using Healthcare.gov by April 19, the end of the open-enrollment period. But perhaps more surprising is that, according to federal data released Wednesday to ProPublica, there have been...
READ MORE

Cancers Related to 9/11 Rescue and Cleanup May Claim 3000 Additional Lives

Sources: We Party Patriots.com, Victims Compensation Fund.org The official number of deaths resulting from the infamous 9/11/2001 attacks stands at 2,996. But by the middle of this century, that number could as much as double. That’s because more than 2,500 of the workers who...
READ MORE

HIV diagnosis rate fell by third in US over decade

Source: Salon.com The rate of HIV infections diagnosed in the United States each year fell by one-third over the past decade, a government study finds. Experts celebrated it as hopeful news that the AIDS epidemic may be slowing in the U.S. The reasons for the drop aren’t clear....
READ MORE

Ocean Medical Center in Brick helps patients understand their medicine

Source: Asbury Park Press Those pages of medical warnings in tiny type that came with your medication and you tossed in the trash? You can leave it in the garbage. Pharmacies are starting to tap into new technology to better help their patients understand their medicine. Since...
READ MORE

Monmouth Ocean Mobile Health Services Wins Award

Monmouth Ocean Hospital Service Corporation Mobile Health Services http://MONOC.org The Monmouth Ocean Hospital Service Corporation (MONOC) is a non-profit company comprised of fifteen acute care hospitals throughout New Jersey. Together this shared services consortium acts as a...
READ MORE

Four Cuban Cancer Vaccines Victims of U.S. blockade

Source: Global Research.ca In 2012, Cuba patented the first therapeutic vaccine in the world against advanced lung cancer, called CIMAVAX-EGF. In January 2013, the island announced the second cancer vaccine, known as Racotumomab. Clinical tests carried out in 86 nations...
READ MORE